RIZZOLIO, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.182
AS - Asia 11.567
EU - Europa 8.004
SA - Sud America 1.128
Continente sconosciuto - Info sul continente non disponibili 734
AF - Africa 236
OC - Oceania 23
Totale 47.874
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.614
CN - Cina 3.665
SG - Singapore 3.403
IT - Italia 2.203
VN - Vietnam 1.625
PL - Polonia 1.506
BR - Brasile 920
HK - Hong Kong 869
DE - Germania 708
IE - Irlanda 659
SE - Svezia 563
UA - Ucraina 557
GB - Regno Unito 462
JP - Giappone 422
FR - Francia 394
CA - Canada 393
KR - Corea 357
IN - India 334
RU - Federazione Russa 260
FI - Finlandia 195
TR - Turchia 174
BD - Bangladesh 131
ID - Indonesia 94
AT - Austria 90
ES - Italia 90
MX - Messico 87
IQ - Iraq 83
NL - Olanda 80
ZA - Sudafrica 73
PK - Pakistan 63
PH - Filippine 61
AR - Argentina 58
BE - Belgio 49
EC - Ecuador 48
TH - Thailandia 46
IR - Iran 42
BJ - Benin 33
CH - Svizzera 33
MA - Marocco 33
UZ - Uzbekistan 33
TW - Taiwan 30
VE - Venezuela 28
CO - Colombia 26
JO - Giordania 24
LT - Lituania 23
CL - Cile 21
SA - Arabia Saudita 20
GR - Grecia 19
AU - Australia 18
KE - Kenya 18
CR - Costa Rica 17
EU - Europa 17
EG - Egitto 14
JM - Giamaica 14
BG - Bulgaria 13
CZ - Repubblica Ceca 13
DZ - Algeria 13
AE - Emirati Arabi Uniti 12
PT - Portogallo 12
AL - Albania 11
PY - Paraguay 11
DK - Danimarca 10
RO - Romania 10
MY - Malesia 9
TN - Tunisia 9
TT - Trinidad e Tobago 9
NG - Nigeria 8
SI - Slovenia 8
GT - Guatemala 7
HN - Honduras 7
KZ - Kazakistan 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
HR - Croazia 6
IL - Israele 6
NI - Nicaragua 6
NP - Nepal 6
RS - Serbia 6
SN - Senegal 6
GE - Georgia 5
LB - Libano 5
NZ - Nuova Zelanda 5
OM - Oman 5
AM - Armenia 4
AZ - Azerbaigian 4
BH - Bahrain 4
EE - Estonia 4
LR - Liberia 4
NO - Norvegia 4
PA - Panama 4
PE - Perù 4
QA - Qatar 4
UY - Uruguay 4
AO - Angola 3
BN - Brunei Darussalam 3
HU - Ungheria 3
KH - Cambogia 3
MM - Myanmar 3
PR - Porto Rico 3
Totale 47.100
Salva come PNG Salva come JPEG
Città #
Ashburn 3.575
Woodbridge 3.154
Fairfield 2.164
Singapore 1.758
Warsaw 1.494
Chandler 1.391
Houston 1.161
Ann Arbor 1.154
Council Bluffs 1.123
San Jose 1.079
Dallas 1.044
Seattle 958
Jacksonville 861
Hong Kong 828
Cambridge 719
Wilmington 680
Dublin 592
Ho Chi Minh City 451
Hanoi 394
Beijing 349
New York 333
Boardman 321
Jinan 318
Seoul 317
Tokyo 316
Mestre 284
Los Angeles 276
Venice 274
Nanjing 260
Dearborn 228
Shenyang 224
Columbus 221
Guangzhou 203
Venezia 196
The Dalles 188
Andover 184
Boston 175
Santa Clara 172
Hefei 161
San Mateo 151
Mülheim 149
Toronto 141
Hebei 139
Lauterbourg 139
Princeton 130
Izmir 129
Ottawa 120
San Diego 120
Munich 115
Hangzhou 104
São Paulo 101
Milan 98
Tianjin 98
Changsha 97
Frankfurt am Main 96
Zhengzhou 96
Helsinki 92
Nanchang 90
Orem 87
Bengaluru 85
Taizhou 83
Altamura 82
Chicago 82
Haikou 77
Jakarta 74
Da Nang 72
Padova 72
London 71
Taiyuan 71
Buffalo 69
Haiphong 66
Ningbo 60
Phoenix 55
Vienna 55
Jiaxing 54
Atlanta 52
Brooklyn 51
Johannesburg 50
San Paolo di Civitate 50
Brussels 46
Chennai 45
Redondo Beach 45
Montreal 44
Moscow 43
Nuremberg 43
Redwood City 42
Rome 42
Pune 40
Fuzhou 39
Des Moines 38
Shanghai 37
Memphis 36
North Bergen 35
Washington 35
Cotonou 33
Rio de Janeiro 33
Amsterdam 32
Denver 32
Menlo Park 31
Mexico City 28
Totale 34.002
Salva come PNG Salva come JPEG
Nome #
Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancer 673
Bottom-Up Synthesis of Carbon Nanoparticles with Higher Doxorubicin Efficacy 635
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? 595
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer 584
Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications 533
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects 495
Highly conserved non-coding sequences and the 18q critical region for short stature: A common mechanism of disease? 493
Glucose Detection Devices and Methods Based on Metal–Organic Frameworks and Related Materials 485
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activity on human ovarian cancer cell lines 471
pRb controls estrogen receptor alpha protein stability and activity 463
The history of nanoscience and nanotechnology: From chemical-physical applications to nanomedicine 463
A guide to PIN1 function and mutations across cancers 460
A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients 455
Enhanced Chemotherapeutic Behavior of Open-Caged DNA@Doxorubicin Nanostructures for Cancer Cells 454
Carbon-dots from sugars and ascorbic acid: Role of the precursors on morphology, properties, toxicity and drug uptake 454
Hyaluronan esters drive smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells 446
Phamacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer 439
Recent advances of electrochemical and optical enzyme-free glucose sensors operating at physiological conditions 437
An effective multi-stage liposomal DNA origami nanosystem for in vivo cancer therapy 432
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor 428
Palladacyclopentadienyl complexes bearing purine-based N-heterocyclic carbenes: A new class of promising antiproliferative agents against human ovarian cancer 423
Self-Therapeutic Nanomaterials for Cancer Therapy: A Review 418
Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy 417
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 417
DNA nanotechnology for cancer therapy 413
The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer 410
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research 402
The anticancer activity of an air-stable Pd(i)-NHC (NHC = N-heterocyclic carbene) dimer 401
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer 400
Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands 400
Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin 397
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression 382
Androgen receptor serine 81 mediates Pin1 interaction and activity 380
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017) 371
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 347
The Clinical translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes 347
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy 344
Palladium (0) olefin complexes bearing purine-based N-heterocyclic carbenes and 1,3,5-triaza-7-phosphaadamantane (PTA): Synthesis, characterization and antiproliferative activity toward human ovarian cancer cell lines 343
Adenosine receptor ligands in clinical trials 342
MTHFR-1298 A > C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 341
A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28 335
Epigenetic analysis of the critical region I for premature ovarian failure: Demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome 331
Identification and characterization of a new reversible MAGL inhibitor 331
Allyl palladium complexes bearing carbohydrate-based N-heterocyclic carbenes: Anticancer agents for selective and potent in vitro cytotoxicity 331
A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males 330
Improved Synthesis, Anticancer Activity and Electrochemical Characterization of Unusual Zwitterionic Palladium Compounds with a Ten‐Term Coordinative Ring 330
Supercritical CO2 extraction of natural antibacterials from low value weeds and agro-waste 328
Highly Selective Salicylketoxime-Based Estrogen Receptor beta Agonists Display Antiproliferative Activities in a Glioma Model 326
Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 320
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation 319
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 316
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin 316
Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells 315
Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls 314
Pin1 and nuclear receptors: A new language? 313
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 310
Metabolomics biomarkers of frailty in elderly breast cancer patients 305
RB gene family: Genome-wide ChIP approaches could open undiscovered roads 305
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors 305
Chromosomal rearrangements in Xq and premature ovarian failure: Mapping of 25 new cases and review of the literature 304
Cyclic Ketoximes as Estrogen Receptor Selective Agonists 304
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 303
X chromosome and ovarian failure 301
Synthesis and Antimicrobial Evaluation of Bis-morpholine Triazine Quaternary Ammonium Salts 301
Dissecting Pin1 and phospho-pRb regulation 299
Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt's lymphoma cell lines 298
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 297
STARD3: A Prospective Target for Cancer Therapy 297
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 295
Upconversion-mediated Boltzmann thermometry in double-layered Bi2SiO5:Yb3+,Tm3+@SiO2hollow nanoparticles 294
Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells 293
CDK inhibitors: from the bench to clinical trials 292
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models 291
Palladium(II)-η3-Allyl Complexes Bearing N-Trifluoromethyl N-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer Tumoroids 290
Critical choices for modeling breast cancer in transgenic mouse models 288
Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: A hypothesis 285
2D metal azolate framework as nanozyme for amperometric detection of glucose at physiological pH and alkaline medium 285
Spatial and temporal expression of POF1B, a gene expressed in epithelia 284
Fluorescent carbon nanoparticles in medicine for cancer therapy 283
Pharmaco-metabolomics: An emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets 281
Fluorescent molecularly imprinted nanogels for the detection of anticancer drugs in human plasma 279
Nanomedicine in cancer pathology 279
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 278
Emerging molecular networks in Burkitt's lymphoma 274
Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease 273
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer 272
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors 272
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2NS) for Ovarian Cancer Therapy 272
Identification of new fyn kinase inhibitors using a FLAP-based approach 268
Research highlights. Overcoming BRAF resistance to PLX4032 by AKT inhibition in PTEN-deficient melanoma cells 263
Fluorescent Carbon Nanoparticles in Medicine for Cancer Therapy: An Update 263
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors 262
A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitor 259
Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B 258
Cancer extracellular vesicles: Next-generation diagnostic and drug delivery nanotools 258
Application of MM-PBSA methods in virtual screening 255
Synthesis and comparative study of the anticancer activity of η3-allyl palladium(II) complexes bearing N-heterocyclic carbenes as ancillary ligands 254
Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer 254
Microfluidic organoids‐on‐a‐chip: Quantum leap in cancer research 249
Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer 247
Totale 35.124
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.105 0 0 330 625 383 40 221 194 97 740 1.014 461
2022/20233.883 297 384 68 445 366 1.110 50 284 482 32 291 74
2023/20241.937 103 110 72 91 261 443 63 124 216 48 190 216
2024/20253.755 59 98 262 280 299 228 441 398 446 425 546 273
2025/202615.476 961 736 1.707 976 1.597 1.082 2.075 812 2.061 1.602 663 1.204
2026/20272.088 1.268 605 215 0 0 0 0 0 0 0 0 0
Totale 47.874